0.75 USD
↘ 0.03 (3.85%)AT CLOSE (11:59 AM EDT)
NeuroSense Therapeutics Ltd. Ordinary Shares
NRSNNASDAQ • USD
0.75
↘ 0.00 (0.01%)
POST MARKET (AS OF 05:30 PM EDT)
Post Market
AS OF 05:30 PM EDT
0.75
↘ 0.00 (0.01%)
Market: CLOSED
Open?$0.78
High?$0.83
Low?$0.73
Prev. Close?$0.78
Volume?102.1K
Avg. Volume?N/A
VWAP?$0.78
Bid / Ask
Bid?$0.62 × 100
Ask?$0.93 × 100
Spread?$0.31
Midpoint?$0.78
Valuation & Ratios
Market Cap?28.2M
Shares Out?32.6M
Float?23.1M
Float %?65.3%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
NRSN is currently priced at $0.75. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9 and a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?83
Piotroski F-Score?0/9Weak
Altman Z-Score?-151.50Distress
Confidence?26%Very Low
Short InterestModerate
Short % of Float?2.11%Low
Short Interest?487.3K
Days to Cover?3.6
Free Float23.1M
Avg Daily Volume135.3K
Settlement Date2026-05-15